BackCorcept Therapeutics Overview

Corcept Therapeutics Receivables

Track Corcept Therapeutics's receivables ($110M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$111.06M
↑ 51.04% YoYΔ $37.53M vs prior year quarter

Peer trimmed avg / median

Loading

Corcept Therapeutics Receivables History

Loading

Corcept Therapeutics vs. peers: Receivables Comparison

Loading

Corcept Therapeutics Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Corcept Therapeutics (CORT) FAQ

Corcept Therapeutics (CORT) currently reports a receivables of $110M as of September 2026. That compares with $74M in the prior-year period — up 51.0% year over year. Use the charts on this page to explore Corcept Therapeutics's receivables history and peer comparisons.

Corcept Therapeutics's receivables increased from $74M to $110M — a 51.0% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Corcept Therapeutics reported $110M in receivables as of September 2026. That compares with $74M in the prior-year period — up 51.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current receivables of $110M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Corcept Therapeutics, and consider following CORT for alerts when major investors trade the stock.

Corcept Therapeutics is classified in the Healthcare sector. On receivables, it currently shows $110M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CORT with unrelated industries.